Literature DB >> 11555322

Aspects on the pathophysiology of migraine and cluster headache.

L Edvinsson1.   

Abstract

The specific cause of migraine headache remains unknown. Current theories suggest that the initiation of a migraine attack involves a primary CNS dysfunction with subsequent activation of the trigeminovascular system. Studies in patients have revealed a clear association between headache and the release of the neuropeptide calcitonin gene-related peptide, probably from C fibres. In cluster headache and in a case of chronic paroxysmal headache there was in addition release of the parasympathetic neuropeptide vasoactive intestinal peptide, which was associated with headache, nasal congestion and rhinorrhea. Triptan administration, activating the 5-HT(1B/1D) receptors, caused the headache to subside and the neuropeptide release to normalise. These data suggest the involvement of sensory and parasympathetic mechanisms in the pathophysiology of primary headaches.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11555322     DOI: 10.1034/j.1600-0773.2001.d01-137.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  11 in total

1.  The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.

Authors:  Valérie Kayser; Bertrand Aubel; Michel Hamon; Sylvie Bourgoin
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 2.  Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

Authors:  L Edvinsson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  The role of myofascial trigger points in musculoskeletal pain syndromes of the head and neck.

Authors:  César Fernández-de-Las-Peñas; David Simons; Maria Luz Cuadrado; Juan Pareja
Journal:  Curr Pain Headache Rep       Date:  2007-10

4.  Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.

Authors:  Tejal Choksi; Debbie L Hay; Stephen Legon; David R Poyner; Stefanie Hagner; Stephen R Bloom; David M Smith
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

5.  Effect of carbon dioxide on calcitonin gene-related peptide secretion from trigeminal neurons.

Authors:  Carrie Vause; Elizabeth Bowen; Egilius Spierings; Paul Durham
Journal:  Headache       Date:  2007 Nov-Dec       Impact factor: 5.887

6.  White matter disintegration in cluster headache.

Authors:  Nikoletta Szabó; Zsigmond Tamás Kincses; Árpád Párdutz; Eszter Tóth; Délia Szok; Gergő Csete; László Vécsei
Journal:  J Headache Pain       Date:  2013-07-24       Impact factor: 7.277

7.  Quantitative magnetic resonance imaging of the upper trapezius muscles - assessment of myofascial trigger points in patients with migraine.

Authors:  Nico Sollmann; Nina Mathonia; Dominik Weidlich; Michaela Bonfert; Sebastian A Schroeder; Katharina A Badura; Tabea Renner; Florian Trepte-Freisleder; Carl Ganter; Sandro M Krieg; Claus Zimmer; Ernst J Rummeny; Dimitrios C Karampinos; Thomas Baum; Mirjam N Landgraf; Florian Heinen
Journal:  J Headache Pain       Date:  2019-01-18       Impact factor: 7.277

8.  Cranial Autonomic Features in Migraine and Migrainous Features in Cluster Headache.

Authors:  Derya Uluduz; Semih Ayta; Aynur Özge; Osman Özgür Yalin; Guülhan Örekici Temel; Bahar Taşdelen
Journal:  Noro Psikiyatr Ars       Date:  2016-07-15       Impact factor: 1.339

Review 9.  Headache in essential thrombocythaemia.

Authors:  R Frewin; A Dowson
Journal:  Int J Clin Pract       Date:  2012-08-14       Impact factor: 2.503

Review 10.  Hypervigilance, Allostatic Load, and Migraine Prevention: Antibodies to CGRP or Receptor.

Authors:  Andrew Blumenfeld; Paul L Durham; Alexander Feoktistov; Debbie L Hay; Andrew F Russo; Ira Turner
Journal:  Neurol Ther       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.